Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 4
2007 7
2008 1
2010 2
2011 8
2012 5
2013 5
2014 2
2015 4
2016 2
2017 3
2018 8
2019 12
2020 7
2021 5
2022 1
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.
Larsen EL, Nilius H, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Goetze JP, Bakchoul T, Nagler M. Larsen EL, et al. Among authors: vishnu p. JAMA Netw Open. 2024 Mar 4;7(3):e243786. doi: 10.1001/jamanetworkopen.2024.3786. JAMA Netw Open. 2024. PMID: 38530310 Free PMC article.
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.
McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, Zemla T, Ashrani A, Tafur A, Perepu U, Anderson D, Gundabolu K, Kuzma C, Perez Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Houghton DE, Vishnu P, Loprinzi CL. McBane RD 2nd, et al. Among authors: vishnu p. J Thromb Haemost. 2020 Feb;18(2):411-421. doi: 10.1111/jth.14662. Epub 2019 Nov 28. J Thromb Haemost. 2020. PMID: 31630479 Free article. Clinical Trial.
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.
Nilius H, Hamzeh-Cognasse H, Hastings J, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Bakchoul T, Cognasse F, Nagler M. Nilius H, et al. Among authors: vishnu p. Blood Adv. 2024 Jun 11;8(11):2825-2834. doi: 10.1182/bloodadvances.2024012782. Blood Adv. 2024. PMID: 38588487 Free PMC article.
Diagnosis and Management of Genetic Iron Overload Disorders.
Palmer WC, Vishnu P, Sanchez W, Aqel B, Riegert-Johnson D, Seaman LAK, Bowman AW, Rivera CE. Palmer WC, et al. Among authors: vishnu p. J Gen Intern Med. 2018 Dec;33(12):2230-2236. doi: 10.1007/s11606-018-4669-2. Epub 2018 Sep 17. J Gen Intern Med. 2018. PMID: 30225768 Free PMC article. Review.
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Nilius H, Cuker A, Haug S, Nakas C, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Kremer Hovinga JA, Vishnu P, Graf L, Kashev A, Sznitman R, Bakchoul T, Nagler M. Nilius H, et al. Among authors: vishnu p. EClinicalMedicine. 2022 Nov 24;55:101745. doi: 10.1016/j.eclinm.2022.101745. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36457646 Free PMC article.
72 results